Mapping the binding site on CD8 beta for MHC class I reveals mutants with enhanced binding

Area of Science:

• Immunology
• Molecular Biology

Background:

• CD8+ T cells are crucial for recognizing virally infected cells via MHC class I.
• The CD8alphabeta heterodimer is a more efficient coreceptor than CD8alphaalpha, enhancing T cell sensitivity to peptide/MHC class I complexes.

Purpose of the Study:

• To investigate the interaction between CD8alphabeta and MHC class I.
• To identify mutations in CD8beta that modulate binding affinity to MHC class I.
• To explore the potential of CD8beta mutants in immunotherapy.

Main Methods:

• Created a panel of CD8beta mutants.
• Assessed binding to MHC class I tetramers.
• Tested coreceptor function using a T cell hybridoma.
• Analyzed CD8alpha mutants in heterodimers with wild-type CD8alpha or CD8beta.

Main Results:

• Identified CD8beta mutations that decrease or enhance binding to MHC class I.
• Demonstrated that CD8beta-enhancing mutants improve coreceptor function.
• Observed binding patterns consistent with different CD8alphabeta orientations on MHC class I.

Conclusions:

• CD8beta mutations can be engineered to modulate T cell coreceptor function.
• Enhanced CD8beta mutants hold potential for cancer immunotherapy by improving T cell responses to weak antigens.
• The orientation of CD8alphabeta binding to MHC class I may differ from CD8alphaalpha or allow for multiple binding positions.